Clinical Trials on Acute Hepatitis in Italy

Total 1136 results

Azienda Ospedaliera di Padova
University of Padova; Regione Veneto

Completed

Different PEG-interferon and Ribavirin Schedules for Chronic Hepatitis C in the Real Clinical Practice.

Hepatitis C Virus | Chronic Liver Disease | Therapeutic Uses | Viral Hepatitis | Antiviral Agents

Italy
Federico II University

Withdrawn

24 VS 48-WEEK TREATMENT WITH PEG-IFN ALPHA-2A IN PATIENTS WITH GENOTYPE 2/3 CHRONIC HEPATITIS C

Chronic Hepatitis C

Italy
Prof. Facchinetti Fabio
Merck Sharp & Dohme LLC

Completed

Menopause is a Critical Factor in Determining Failure of Antiviral Therapy in Women With Chronic Hepatitis C (MEN_EPID)

Chronic Hepatitis C

Italy
University of Modena and Reggio Emilia

Unknown

Efficacy Study to Evaluate the Effect of New Antiviral Drugs on HCV Infection.

Chronic Hepatitis, C Virus

Italy
University of Turin, Italy

Unknown

Pegylated-Interferon and Ribavirin in Hepatitis C Patients With Persistently Normal Alanine Aminotransferase Levels

Chronic Hepatitis C

Italy
Hoffmann-La Roche

Completed

A Study of Peginterferon Alfa-2a With or Without Ribavirin in Participants With Chronic Hepatitis D (CHD)

Hepatitis D, Chronic

Italy
University of Roma La Sapienza

Unknown

Prospective Clinical Study of the Role of the Immune Response, in Relation to Diet, in Patients Affected by Either Chronic Hepatitis C Virus (HCV) Infection or Non Alcoholic Fatty Liver Disease (NAFLD)

Non Alcoholic Fatty Liver Disease | Chronic Hepatitis C Virus

Italy
Azienda Ospedaliero-Universitaria di Parma
AbbVie

Completed

Role of the Host Immunity in the Non-response to Direct Anti-viral Agent (DAA) Therapy

Chronic Hepatitis C

Italy
Azienda Ospedaliero-Universitaria di Parma

Completed

Effect of Boceprevir on HCV-specific T Cell Responses (Boce-Par)

Chronic Hepatitis C

Italy
Azienda Ospedaliera San Camillo Forlanini

Completed

HCV Genotype 1a Shows a Better Virological Response to Antiviral Therapy Than HCV Genotype 1b (genotype)

Chronic Hepatitis C

Italy
University Hospital of Ferrara

Completed

Autoimmune Hepatitis in Pediatric Patients

Autoimmune Hepatitis

Italy
University of Modena and Reggio Emilia
Merck Sharp & Dohme LLC

Unknown

Boceprevir/PegIFN α-2b/Riba in HCV+ Gt1 Menopausal Women, Nonresponders to PegIFN/Riba or Treatment-naives (MEN_BOC) (MEN_BOC)

Menopause | Chronic Hepatitis C

Italy
Istituto Superiore di Sanità

Completed

Observational Study in HCV Chronic Infection

Hepatitis C, Chronic

Italy
University of Turin, Italy

Unknown

Pegylated-Interferon and Ribavirin Plus Metformin in the Treatment of Chronic HCV Infection and Insulin Resistance

Insulin Resistance | Chronic Hepatitis C

Italy
University of Milano Bicocca

Recruiting

Development of a Autoimmune Hepatitis Patient's Database Linked to a Biological Sample Storage (AIH Database)

Autoimmune Hepatitis | Liver Disorder

Italy
Azienda Ospedaliero Universitaria di Cagliari

Completed

Impact on QoL and Cognitive Functioning of New Antiviral Therapies in Subjects With Chronic Hepatitis HCV-related

Cognitive Impairment | Chronic Hepatitis c | Psychiatric Disorders

Italy
University of Bari

Completed

Autoantibodies and Direct-acting Antivirals (BIOEPA)

Viral Hepatitis C | Therapy Adverse Effect

Italy
Rottapharm
Azienda Ospedaliera Universitaria Policlinico

Terminated

Effect of LEGALON SIL on Hepatitis C Virus Recurrence in Stable Liver Transplanted Patients (LEG-SIL-LTX-02)

Hepatitis C Virus Recurrence

Italy
Instituto Grifols, S.A.

Completed

Efficacy and Safety of Intramuscular HBIG Grifols for the Prevention of Recurrence After Liver Transplantation

Hepatitis B, Chronic

Italy
Fondazione IRCCS Ca' Granda, Ospedale Maggiore...

Recruiting

Effectiveness and Safety of Bulevirtide (BLV) Therapy in Patients With Chronic Hepatitis Delta (CHD) in Italy (D-SHIELD) (D-SHIELD)

Hepatitis D

Italy
Fondazione IRCCS Ca' Granda, Ospedale Maggiore...

Completed

Efficacy and Safety of Bulevirtide (BLV) Therapy in HDV Chronic Hepatitis (CHD) in Italy (HEP4Di)

Hepatitis D

Italy
Fondazione IRCCS Ca' Granda, Ospedale Maggiore...

Not yet recruiting

Effectiveness and Clinical Outcomes of Long-term Bulevirtide Monotherapy in Patients With HDV-related Compensated Cirrhosis (SAVE-D)

Hepatitis D

Italy
ReiThera Srl
European Commission

Completed

Study of a Novel Therapeutic Vaccine Against Hepatitis C Using Ad6NSmut and MVA-NSmut in Chronically Infected Patients (HCV004)

Hepatitis C

Italy
University of Roma La Sapienza

Completed

Ribavirin Pre-treatment Followed by Combined Standard Therapy in Hepatitis C Virus (HCV) Recipients (RBV)

Hepatitis C

Italy
Fondazione IRCCS Policlinico San Matteo di Pavia

Not yet recruiting

Risk of Reactivation of Occult Hepatitis B in Cancer Patients During Immunotherapy.

Occult Hepatitis B Infection in Cancer Patients

Italy
IRCCS San Raffaele
Hoffmann-La Roche; Abbott

Unknown

Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Therapy (HAART) in HIV/HCV Coinfected Patients Starting Treatment With Anti-Hepatitis C Virus (HCV) Therapy

HIV Infections | Hepatitis C

Italy
Cytheris SA

Unknown

Dose Escalation of Interleukin-1 (IL-7) Added on Antiviral Treatment and Vaccination in HBeAg-negative Chronic Hepatitis B Virus (HBV) Infected Patients (CONVERT)

Chronic Hepatitis B

France, Italy
Azienda Ospedaliera San Giovanni Battista

Completed

Risk of Hepatitis B Virus Reactivation in Patients Undergoing Allografting

Hematological Malignancies | Hepatitis B Virus | Allograft

Italy
Hoffmann-La Roche

Completed

Analysis of HBV-Specific Immune Response in Patients With HBeAg Negative Chronic Hepatitis B Treated With Pegasys (Peginterferon Alfa-2a (40KD)) - Immunology Sub-Study of ML18253

Hepatitis B, Chronic

Italy
Fondazione Policlinico Universitario Agostino Gemelli...

Completed

Prothrombin Time Predicts Steroid Response in Severe Alcoholic Hepatitis. (AH2023)

Alcoholic Hepatitis

Italy
IRCCS San Raffaele
Hoffmann-La Roche; Abbott

Unknown

Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Therapy (HAART) in HIV/HCV Coinfected Antiretroviral (ARV) Naive Patients Starting Treatment With Anti-HCV Therapy

HIV Infections | Hepatitis C

Italy
Hospices Civils de Lyon

Recruiting

Creation of a Cohort for the Quantitation and Characterization of Circulating Viral RNAs as a New Biomarker of Hepatitis B Functional Cure. (CirB-RNA)

Hepatitis B

France, Italy
Alessandra Mangia

Completed

Puglia HCV Micro-elimination Program (PHCVM)

Hepatitis C

Italy
Casa Sollievo della Sofferenza IRCCS

Completed

Efficacy Study of New Therapeutic Schedules in Naive Hepatitis C Virus (HCV) Patients Infected With Genotype 3 (HCV-3) (genotype-3)

Chronic Hepatitis

Italy
Azienda Ospedaliera Universitaria Policlinico Paolo...

Completed

Elbasvir/Grazoprevir Fixed-Dose Combination for 8 Weeks in G1b Treatment-Naïve, HCV-Infected Patients (EGG-18)

Chronic HCV Hepatitis

Italy
Instituto Grifols, S.A.

Completed

Efficacy and Safety of Niuliva® for the Prevention of Hepatitis B Virus Recurrence in Newly Orthotopic Liver Transplant Recipients

Liver Transplantation | Hepatitis B

Italy
National Cancer Institute, Milan
Associazione Italiana per la Ricerca sul Cancro

Completed

Treatment With IFN After Curative Resection of HCC in HCV-Related Cirrhosis

Liver Cirrhosis | Hepatocellular Carcinoma | Hepatitis C Virus Infection | Hepatic Resection | Interferon Treatment

Italy
sigma-tau i.f.r. S.p.A.
SciClone Pharmaceuticals

Completed

Thymosin Alpha-1 in Combination With Peg-Interferon Alfa- 2a and Ribavirin for the Therapy of Chronic Hepatitis C Nonresponsive to the Combination of IFN and Ribavirin.

Chronic Hepatitis C

Spain, Italy, France, Germany, Greece
ANRS, Emerging Infectious Diseases
EUCLID Clinical Trial Platform

Recruiting

ANRS HB07 IP-Cure-B Proof of Concept (PoC) Clinical Trial. Educating the Liver Immune Environment Through TLR8 Stimulation Followed by NUC Discontinuation (IP-CURE-B)

Hepatitis B, Chronic

France, Germany, Italy, Spain
Catholic University of the Sacred Heart
University of Roma La Sapienza

Completed

Bariatric Surgery Versus Non-alcoholic Steato-hepatitis (BRAVES)

Non Alcoholic Steatohepatitis

Italy
Casa Sollievo della Sofferenza IRCCS

Completed

Antiviral Therapy in Decompensated Hepatitis C Virus (HCV) Cirrhosis

Liver Cirrhosis, Experimental

Italy
Gilead Sciences

Completed

Safety and Efficacy of Ledipasvir/Sofosbuvir (LDV/SOF) Fixed Dose Combination (FDC) for 12 or 24 Weeks in Kidney Transplant Recipients With Chronic HCV Infection

Hepatitis C Virus Infection

France, Austria, Germany, Italy
Sanofi Pasteur, a Sanofi Company

Completed

A Study to Assess the Anamnestic Immune Response in Healthy 4 to 7 Year-old Children After a Primary Vaccination Series With Either HEXAVAC® or INFANRIX®-HEXA

Hepatitis B

Italy
Gilead Sciences

Active, not recruiting

Study to Assess Efficacy and Safety of Bulevirtide in Participants With Chronic Hepatitis Delta (CHD)

Chronic Hepatitis Delta

Germany, Russian Federation, United States, Italy, Sweden
Gilead Sciences

Terminated

Utilization and Efficacy of Tenofovir DF in Adolescents With Chronic Hepatitis B Virus Infection

Hepatitis B

Spain, Italy, United Kingdom, Romania, Belgium, France, Greece
European Society for Blood and Marrow Transplantation

Completed

Current Treatment of HCV Infection After HSCT

Hepatitis C

France, Spain, Italy
Mauro Podda
Associazione Chirurghi Ospedalieri Italiani

Completed

Appendectomy Versus Conservative Treatment for Uncomplicated Acute Appendicitis (ACTUAA)

Acute Appendicitis | Appendectomy | Antibiotic Therapy | Appendicitis Recurrent

Italy
Gilead Sciences

Terminated

Study to Investigate Pharmacokinetics, Safety and Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir (SOF/VEL/VOX) Fixed Dose Combination (FDC) in Adolescents and Children With Chronic Hepatitis C Virus (HCV) Infection

Hepatitis C Virus Infection

Poland, Italy, United Kingdom
Cytheris SA

Completed

Dose Escalation Study of IL-7 and Bi-therapy in HCV Patients Resistant After 12 Weeks of Bi-therapy (ECLIPSE 1) (ECLIPSE 1)

Hepatitis C

France, Switzerland, Italy
Laboratórios Baldacci S.A
Opera CRO, a TIGERMED Group Company

Completed

Performance and Tolerability of the Medical Device LACRIACT

Dry Eye | Photophobia | Contact Lens Acute Red Eye | Discomfort

Italy

3

Subscribe